Laxxon Medical | WebDisclosure

Basculer en Français

10799	Companies
233575	Keywords
162177	Articles
124649	Press releases

Home
Companies
Laxxon Medical

PRESS RELEASE

published on 10/14/2024 at 16:00, 1 year 9 months ago

Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention
Laxxon Medical to showcase innovative oral GLP-1 Agonist micro-tablet at 2024 BIO Europe Convention, aiming to enhance patient compliance. Event aims to discover new partnerships

Laxxon Medical Oral GLP-1 Agonist Patient Compliance Micro-tablet BIO Europe Convention
BRIEF

published on 10/09/2024 at 20:06, 1 year 9 months ago

Laxxon Medical to Present SPID® Technology at CPHI Milan 2024

Laxxon Medical Pharmaceutical Manufacturing SPID® Technology CGMP Printing Technology CPHI Milan 2024
BRIEF

published on 10/09/2024 at 20:06, 1 year 9 months ago

Laxxon Medical présentera la technologie SPID® au CPHI Milan 2024

Laxxon Medical Fabrication Pharmaceutique Technologie SPID® CPHI Milan 2024 Technologie D'impression CGMP
PRESS RELEASE

published on 10/09/2024 at 20:01, 1 year 9 months ago

Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
Laxxon Medical to showcase cGMP Printing Technology at CPHI Milan 2024, unveiling innovative oral drug delivery systems through SPID® Technology

Laxxon Medical SPID® Technology CGMP Printing CPHI Milan Oral Drug Delivery
BRIEF

published on 10/01/2024 at 15:05, 1 year 10 months ago

Laxxon Medical et Adare Pharma Solutions annoncent une coopération conjointe pour la production de formes posologiques orales imprimées en 3D cGMP en Europe et aux États-Unis

Production CGMP Laxxon Medical Adare Pharma Partenariat Pharmaceutique Médicaments Imprimés En 3D
BRIEF

published on 10/01/2024 at 15:05, 1 year 10 months ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US

CGMP Production Laxxon Medical Pharma Partnership 3D Printed Drugs Adare Pharma
PRESS RELEASE

published on 10/01/2024 at 15:00, 1 year 10 months ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
Laxxon Medical & Adare Pharma Cooperate for cGMP 3D Printed Oral Dosage Forms production in Europe & US. Utilizing SPID® Technology by Laxxon & Adare's cGMP-certified facilities

Drug Delivery Laxxon Medical 3D Printed Adare Pharma Solutions CGMP
BRIEF

published on 05/22/2024 at 15:10, 2 years 2 months ago

Laxxon Medical annonce le développement d'un actif GLP-1 oral non invasif

Laxxon Medical Traitement De L'obésité Agoniste Du Récepteur GLP-1 Technologie SPID® Voie 505(b)2
BRIEF

published on 05/22/2024 at 15:10, 2 years 2 months ago

Laxxon Medical Announces Development of Non-Invasive Oral GLP-1 Asset

Obesity Treatment Laxxon Medical GLP-1 Receptor Agonist SPID® Technology 505(b)2 Pathway
PRESS RELEASE

published on 05/22/2024 at 15:05, 2 years 2 months ago

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Laxxon Medical announces development program for LXM.2, a 3D printed oral GLP-1 receptor agonist for obesity treatment, offering an alternative to injections. Utilizes SPID® platform technology for enhanced bioavailability

Obesity Treatment Laxxon Medical GLP-1 LXM.2 3D Printed

Accesswire

Published on 08/04/2026 at 15:00, 22 minutes ago

Infield Minerals Expands Land Position at the Kings Canyon Gold Project in Utah
Published on 08/04/2026 at 15:00, 22 minutes ago

Secure Blockchain's Agentic Solutions Signs First Enterprise AI Customer
Published on 08/04/2026 at 14:30, 52 minutes ago

Agassi Sports Entertainment Launches Global "Let's Play" Pickleball and Padel Platform Initiative
Published on 08/04/2026 at 14:30, 52 minutes ago

Innodata Releases the First Stage of Its AI Cyber Training Suite to Enable AI Coding Agents to Write - and Repair - Secure Code
Published on 08/04/2026 at 14:00, 1 hour 22 minutes ago

GameSquare to Report Q2 2026 Financial Results on August 10, 2026

View all ACCESSWIRE

EQS Group

Published on 08/04/2026 at 15:05, 17 minutes ago

Left Lane Capital Announces New Wave of Senior Promotions and Hires
Published on 08/04/2026 at 14:05, 1 hour 17 minutes ago

Landis+Gyr Adds Senior Leaders to Drive Growth as U.S. Grid Investment Accelerates
Published on 08/04/2026 at 14:05, 1 hour 17 minutes ago

DJI Mic Mini 2S Launches Globally, Equipping Creators with Internal Recording Up to 28 Hours and AI-Upgraded Noise Canceling
Published on 08/04/2026 at 14:05, 1 hour 17 minutes ago

Revolune Announces Service Provider Program with CellCarta, Concept Life Sciences, and Propath UK
Published on 08/04/2026 at 14:00, 1 hour 22 minutes ago

Lünendonk Study underlines q.beyond’s 2028 Strategy: AI orchestration and sector expertise in focus

Les Echos

Published on 08/04/2026 at 08:15, 7 hours 7 minutes ago

Covivio - Modalités de mise à disposition du Rapport Financier Semestriel 2026
Published on 08/04/2026 at 08:15, 7 hours 7 minutes ago

Covivio - Conditions of availability of the 2026 Half-year report
Published on 08/03/2026 at 18:45, 20 hours 37 minutes ago

Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 08/03/2026 at 18:45, 20 hours 37 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 18:35, 20 hours 47 minutes ago

Covivio Hotels - Informations relatives au nombre total de droits de vote et d'actions composant le capital social

View all LES ECHOS COMFI WIRE